ResearchPerspectives: Expert Analysis of the Latest Multiple Myeloma Studies

This activity is supported by educational funding provided by Amgen.

Scroll to the Bottom of this Information to Begin this Course

Release date: June 24, 2016

Valid through: June 23, 2017

Specialty: Hematology, Oncology

Topic: Multiple Myeloma

Media: Internet

Estimated Time to Complete Activity: 60 minutes

Target Audience

A national audience of hematologist-oncologists and other clinicians interested in research and management of multiple myeloma.

Program Overview

This CME activity focuses on the clinical impact of 3 recently published studies involving the management of patients with multiple myeloma.

Listen to the 3 article summaries and key findings that may impact your practice.

Test your clinical skills after listening to the commentary.


  • Risk stratification
  • The ENDEAVOR trial
  • Anti-CD38 monoclonal antibody

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Summarize the latest research developments in the diagnosis and treatment of multiple myeloma
  • Discuss how new data and recommendations can impact clinical practices to improve multiple myeloma care
  • Incorporate evidence-based research into clinical practice

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credits

All other healthcare professionals completing this course will be issued a statement of participation.


Joseph Mikhael, MD, MEd
Professor of Medicine, Mayo College of Medicine
Associate Dean, Mayo School of Graduate Medical Education
Deputy Director – Education, Mayo Clinic Cancer Center
Associate Medical Director, Department of Development
Phoenix, Arizona

Physician Continuing Medical Education

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:

Joseph Mikhael, MD, MEd
  • Research Support: AbbVie, Celgene, Onyx, Sanofi

The faculty for this activity has disclosed that there will be no discussion about the use of products for non-FDA approved applications.

Additional content planners
The following have no significant relationship to disclose:

Alex Howson, PhD (medical writer)

Annenberg Center for Health Sciences

John Bayliss, VP, Business Development, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.

Disclosure of Unlabeled Use

The faculty for this activity has disclosed that there will be no discussion about the use of products for non-FDA approved applications.